Pathological response and safety of FOLFOXIRI for neoadjuvant treatment of high-risk relapsed locally advanced colon cancer: study protocol for a single-arm, open-label phase II trial

INTRODUCTION: Neoadjuvant chemotherapy (NAC) has been demonstrated effective in several tumours, but its benefit has not yet been elucidated in colorectal cancer, especially locally advanced colorectal cancer (LACRC). METHODS AND ANALYSIS: This is a single-arm, open-label, prospective phase II explo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaorong, Leng, Weibing, Zhou, YuWen, Yu, Yongyang, Meng, Wenjian, Cao, Peng, Wang, Ziqiang, Qiu, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890744/
https://www.ncbi.nlm.nih.gov/pubmed/36720570
http://dx.doi.org/10.1136/bmjopen-2022-062659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890744/
https://www.ncbi.nlm.nih.gov/pubmed/36720570
http://dx.doi.org/10.1136/bmjopen-2022-062659

Ejemplares similares